It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
Breast cancer detection in its early stages significantly improves survival rates, according to medical experts. While ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Technology could soon do more than assist doctors. Thanks to advancements in cancer-identifying AI, it could actively save ...
If you have breast cancer, you will have changes in your breast. These may be lumps or changes in the size or color of your breast, or changes in the appearance of your nipples. Breast cancer ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
Artificial Intelligence can improve breast cancer detection and reduce workload on physicians, according to a new study from Germany featuring over 461,000 women.
Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback